Heron Therapeutics Stock (NASDAQ: HRTX) stock price, news, charts, stock research, profile.
You can purchase shares of Heron Therapeutics (NASDAQ:HRTX) through any online brokerage.
Other companies in Heron Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Cabaletta Bio (NASDAQ:CABA), Skye Bioscience (NASDAQ:SKYE), Galectin Therapeutics (NASDAQ:GALT) and Atossa Therapeutics (NASDAQ:ATOS).
Heron Therapeutics has a consensus price target of $6.75.
The stock price for Heron Therapeutics (NASDAQ: HRTX) is $1.22 last updated November 14, 2024 at 7:50 PM EST.
There are no upcoming dividends for Heron Therapeutics.
Heron Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Heron Therapeutics.
Heron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.